Boxes containing the Pfizer-BioNTech COVID-19 vaccine are prepared to be shipped at the Pfizer Global Supply Kalamazoo manufacturing plant in Portage, Michigan, US, December 13, 2020.
Pfizer Inc and Germany’s BioNTech SE are expected to submit an emergency use authorization request as early as Tuesday to the US Food and Drug Administration for vaccines for children aged six months to 5 years, theCoronavirus vaccines for children younger than 5 could be available as soon as end-February under a plan that would lead to the potential authorization of a two-shot regimen in the coming weeks, theThe report says that the FDA urged the companies to submit the application so that...
“The idea is, let’s go ahead and start the review of two doses,” the report quoted one of the people familiar with the situation as saying. “If the data holds up in the submission, you could start kids on their primary baseline months earlier than if you don’t do anything until the third-dose data comes in.
The company amended the study because children between the ages of 2 and 4 who were given two 3-microgram doses of the vaccine did not have the same immune response that a larger dose of the vaccine generated in older children.
Not the kids please 🙏 God
Oh just fokof
for what? you also wannna kill kids?
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: Moneyweb - 🏆 5. / 77 더 많은 것을 읽으십시오 »